Genetic polymorphisms in the ITPKC gene and cervical squamous cell carcinoma risk

Cancer Immunology, Immunotherapy

Volumn 61, Issue 11, 2012, Pages 2153-2159

  Yang, Yuh Cheng ^a,b   Chang, Tzu Yang ^a   Chen, Tze Chien ^a   Chang, Shih Chuan ^a   Chen, Wei Fang ^a   Chan, Hui Wen ^a   Lin, Wen Shan ^a   Wu, Fu Ting ^a   Lee, Yann Jinn ^a,b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

Cervical cancer; HPV; Immunity; ITPKC; Polymorphism

Indexed keywords

INOSITOL TRISPHOSPHATE 3 KINASE;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; ITPKC GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; UTERINE CERVIX CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INCIDENCE; MIDDLE AGED; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK; TAIWAN; UTERINE CERVICAL NEOPLASMS;

EID: 84870977166     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1280-y     Document Type: Article

References (29)

1. Chen CA, Hsieh CY (2004) Recent advances and problems in primary therapy for cervical cancer in Taiwan. J Formos Med Assoc 103:511-518
2. Munoz N (2000) Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1-5. doi:10.1016/S1386-6532(00)00125-6
3. Magnusson PK, Sparen P, Gyllensten UB (1999) Genetic link to cervical tumours. Nature 400:29-30. doi:10.1038/21801
4. Ozsaran AA, Ates T, Dikmen Y, Zeytinoglu A, Terek C, Erhan Y, Ozacar T, Bilgic A (1999) Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy. Eur J Gynaecol Oncol 20:127-130
5. Serraino D, Carrieri P, Pradier C, Bidoli E, Dorrucci M, Ghetti E, Schiesari A, Zucconi R, Pezzotti P, Dellamonica P, Franceschi S, Rezza G (1999) Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer 82:334-337. doi: 10.1002/(SICI)1097-0215(19990730
6. Park TK, Kim SN (1989) Cell-mediated immunity in patients with invasive carcinoma of the cervix. Yonsei Med J 30:164-172
7. Das S, Karim S, Datta Ray C, Maiti AK, Ghosh SK, Chaudhury K (2007) Peripheral blood lymphocyte subpopulations in patients with cervical cancer. Int J Gynaecol Obstet 98:143-146. doi: 10.1016/j.ijgo.2007.04.011
8. Kadish AS, Timmins P, Wang Y, Ho GY, Burk RD, Ketz J, He W, Romney SL, Johnson A, Angeletti R, Abadi M (2002) Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomarkers Prev 11:483-488
9. Coleman N, Birley HD, Renton AM, Hanna NF, Ryait BK, Byrne M, Taylor-Robinson D, Stanley MA (1994) Immunological events in regressing genital warts. Am J Clin Pathol 102:768-774
10. de Jong A, van Poelgeest MI, van der Hulst JM, Drijfhout JW, Fleuren GJ, Melief CJ, Kenter G, Offringa R, van der Burg SH (2004) Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res 64:5449-5455. doi:10.1158/ 0008-5472.CAN-04-0831
11. Clerici M, Merola M, Ferrario E, Trabattoni D, Villa ML, Stefanon B, Venzon DJ, Shearer GM, De Palo G, Clerici E (1997) Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 89:245-250. doi:10.1093/jnci/89.3.245
12. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, Nakamura Y, Yanagawa H, Wakui K, Fukushima Y, Kishi F, Hamamoto K, Terai M, Sato Y, Ouchi K, Saji T, Nariai A, Kaburagi Y, Yoshikawa T, Suzuki K, Tanaka T, Nagai T, Cho H, Fujino A, Sekine A, Nakamichi R, Tsunoda T, Kawasaki T, Hata A (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35-42. doi:10.1038/ng.2007.59
13. Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature 361:315-325. doi:10.1038/361315a0
14. Imboden JB, Pattison G (1987) Regulation of inositol 1,4,5-trisphosphate kinase activity after stimulation of human T cell antigen receptor. J Clin Invest 79:1538-1541. doi:10.1172/ JCI112986
15. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265. doi:10.1093/bioinformatics/bth457
16. Chen YY, You SL, Chen CA, Shih LY, Koong SL, Chao KY, Hsiao ML, Hsieh CY, Chen CJ (2009) Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences. Br J Cancer 101:174-177. doi:10.1038/sj.bjc. 6605139
17. Hildesheim A, Wang SS (2002) Host and viral genetics and risk of cervical cancer: a review. Virus Res 89:229-240. doi: 10.1016/S0168-1702(02)00191-0
18. Madeleine MM, Johnson LG, Smith AG, Hansen JA, Nisperos BB, Li S, Zhao LP, Daling JR, Schwartz SM, Galloway DA (2008) Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res 68:3532-3539. doi:10.1158/0008-5472. CAN-07-6471
19. Chan DP, Cheung TH, Tam AO, Cheung JL, Yim SF, Lo KW, Siu NS, Zhou DX, Chan PK (2005) Risk association between human leukocyte antigen-A allele and high-risk humanpapillomavirus infection for cervical neoplasia in Chinese women. J Infect Dis 192:1749-1756. doi:10.1086/497342
20. Liang J, Xu A, Xie Y, Awonuga AO, Lin Z (2008) Some but not all of HLA-II alleles are associated with cervical cancer in Chinese women. Cancer Genet Cytogenet 187:95-100. doi:10.1016/ j.cancergencyto.2008.07.011
21. Wang SS, Hildesheim A, Gao X, Schiffman M, Herrero R, Bratti MC, Sherman ME, Barnes WA, Greenberg MD, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Glass AG, Burk RD, Karacki P, Carrington M (2002) Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J Infect Dis 186:598-605. doi:10.1086/342295
22. Chen X, Han S, Wang S, Zhou X, Zhang M, Dong J, Shi X, Qian N, Wang X, Wei Q, Shen H, Hu Z (2009) Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin Cancer Res 15:400-405. doi:10.1158/ 1078-0432.CCR-08-1829
23. Grimm C, Watrowski R, Baumuhlner K, Natter C, Tong D, Wolf A, Zeillinger R, Leodolter S, Reinthaller A, Hefler L (2011) Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia. Gynecol Oncol 121:537-541. doi: 10.1016/j.ygyno.2011.02.019
24. Castro FA, Haimila K, Sareneva I, Schmitt M, Lorenzo J, Kunkel N, Kumar R, Forsti A, Kjellberg L, Hallmans G, Lehtinen M, Hemminki K, Pawlita M (2009) Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population -a candidate gene approach. Int J Cancer 125:1851-1858. doi:10.1002/ijc.24529
25. Lai HC, Chang CC, Lin YW, Chen SF, Yu MH, Nieh S, Chu TW, Chu TY (2005) Genetic polymorphism of the interferon-gamma gene in cervical carcinogenesis. Int J Cancer 113:712-718. doi: 10.1002/ijc.20637
26. Su TH, Chang TY, Lee YJ, Chen CK, Liu HF, Chu CC, Lin M, Wang PT, Huang WC, Chen TC, Yang YC (2007) CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis 28:1237-1240. doi:10.1093/carcin/bgm043
27. Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM (2005) TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis 191:969-976. doi:10.1086/427826
28. Feske S (2007) Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 7:690-702. doi:10.1038/nri2152
29. Rao A, Luo C, Hogan PG (1997) Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15:707-747. doi:10.1146/annurev. immunol.15.1.707